|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation, depletion, amortization and impairment | |||||
| Impairment of goodwill | |||||
| Deferred income tax expense (benefit) | |||||
| Stock-based compensation | |||||
| Net gain on asset disposals | |||||
| Credit loss expense | |||||
| Gain on early debt extinguishment | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities of discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions, net of cash acquired - NexTier | |||||
| Acquisitions, net of cash acquired - Ulterra | |||||
| Purchases of property and equipment | |||||
| Proceeds from disposal of assets and insurance claims | |||||
| Investment in unconsolidated affiliate | |||||
| Proceeds from disposal of assets, including insurance recoveries | |||||
| Other | |||||
| Net cash provided by investing activities of discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Purchases of treasury stock | |||||
| Dividends paid | |||||
| Proceeds from borrowings under revolving credit facility | |||||
| Repayment of borrowings under revolving credit facility | |||||
| Proceeds from issuance of senior notes | |||||
| Repayment of senior notes | |||||
| Repayment of term loan | |||||
| Payments of finance leases | |||||
| Debt issuance costs | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Net cash (paid) received during the year for: | |||||
| Interest, net of capitalized interest of $734 in 2025, $1,334 in 2024, and $1,692 in 2023 | |||||
| Income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Net decrease in payables for purchases of property and equipment | |||||
| Net decrease in deposits on equipment purchases | |||||
| Issuance of common stock for business acquisitions | |||||
| Cashless exercise of stock options | |||||
| Purchases of property and equipment through exchange of lease right of use asset | |||||
| Derecognition of right of use asset | |||||
Loading...